Inhibrx Biosciences, Inc. · NASDAQ:INBX

Forsyth Douglas bought 2,500 Inhibrx Biosciences, Inc. shares (Form 4)

Traded Sep 8, 2026 · Filed Sep 8, 2026

On Sep 8, 2026, Forsyth Douglas (Director) bought 2,500 Inhibrx Biosciences, Inc. shares at US$114.65 for US$287K, leaving 227,064 shares. Filed Sep 8, 2026 (Form 4).

Bought
2,500 shares
Price
US$114.65
Value
US$287K
Holding after
227,064 shares (held indirectly)
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 8, 2026Common StockBuy2,500US$114.65227,064Indirect

Source

View original at SEC

Related